US Patent 11407732 Tricyclic degraders of Ikaros and Aiolos

Patent 11407732 was granted and assigned to C4 Therapeutics on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

C4 Therapeutics

Current Assignee

C4 Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11407732

Date of Patent

August 9, 2022

Patent Application Number

17498617

Date Filed

October 11, 2021

Patent Citations

‌

US Patent 11185543 Antiproliferative compounds and methods of use thereof

Patent Citations Received

‌

US Patent 12091397 Dihydroquinolinones for medical treatment

‌

US Patent 11802131 Glutarimides for medical treatment

Patent Primary Examiner

‌

Heidi Reese

Tricyclic cereblon binders for the degradation of Ikaros or Aiolos by the ubiquitin proteasome pathway for therapeutic applications are described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11407732 Tricyclic degraders of Ikaros and Aiolos

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API